Healthcare - Biotechnology - NASDAQ - US
$ 3.66
-1.35 %
$ 2.21 B
Market Cap
-11.44
P/E
Price Target
Average
63.93%
Revenue Forecast
Estimate
736.15%
EBIT
Estimate
--56.33%
Net Income
Estimate
44.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Geron Corporation
Wall Street analysts predict an average 1-year price target for GERN of $6 , with forecasts ranging from a low of $4.5 to a high of $8 .
GERN Lowest Price Target
Wall Street Target
4.5 USD
22.95%
GERN Average Price Target
Wall Street Target
6 USD
63.93%
GERN Highest Price Target
Wall Street Target
8 USD
118.58%
REVENUE FORECAST
Revenue Forecast Chart GERN
EBIT FORECAST
EBIT Forecast Chart GERN
NET INCOME FORECAST
Net Income Chart GERN